Royce & Associates’s Hims & Hers Health HIMS Stock Holding History

Royce & Associates’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-45,514	Closed	-$2.27M	–	798
2025 Q2	$2.27M	Buy	+45,514	New	+$2.06M	0.02%	580
2025 Q1	–	Sell	-153,000	Closed	-$3.7M	–	831
2024 Q4	$3.7M	Sell	153,000 -188,000	-55%	-$4.66M	0.03%	540
2024 Q3	$6.28M	Buy	341,000 +49,500	+17%	+$886K	0.06%	425
2024 Q2	$5.89M	Sell	291,500 -145,500	-33%	-$2.42M	0.06%	442
2024 Q1	$6.76M	Buy	437,000 +237,000	+119%	+$2.67M	0.06%	433
2023 Q4	$1.78M	Hold	200,000	–	–	0.02%	659
2023 Q3	$1.26M	Sell	200,000 -220,000	-52%	-$1.64M	0.01%	708
2023 Q2	$3.95M	Hold	420,000	–	–	0.04%	554
2023 Q1	$4.17M	Buy	420,000 +32,000	+8%	+$280K	0.04%	525
2022 Q4	$2.49M	Buy	388,000 +188,000	+94%	+$1.07M	0.03%	612
2022 Q3	$1.12M	Hold	200,000	–	–	0.01%	717
2022 Q2	$906K	Hold	200,000	–	–	0.01%	765
2022 Q1	$1.07M	Hold	200,000	–	–	0.01%	801
2021 Q4	$1.31M	Sell	200,000 -640,000	-76%	-$4.63M	0.01%	776
2021 Q3	$6.33M	Hold	840,000	–	–	0.05%	532
2021 Q2	$9.15M	Hold	840,000	–	–	0.06%	451
2021 Q1	$11.1M	Buy	+840,000	New	+$14.1M	0.07%	413

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royce & Associates's HIMS Position: Q3 2025 in Review

Royce & Associates sold out of Hims & Hers Health (HIMS) in Q3 2025, closing a stake of 45,514 shares — an estimated $2.27M sold.

Royce & Associates first reported a position in HIMS in Q1 2021 and held it in 17 quarters. The position peaked at $11.1M in Q1 2021. 512 funds tracked by Wall St. Rank hold HIMS as of Q3 2025.

Royce & Associates reported no remaining Hims & Hers Health position as of Q3 2025 after selling out during the quarter.
Royce & Associates sold 45,514 Hims & Hers Health shares in Q3 2025, an estimated $2.27M.
Royce & Associates first reported a position in Hims & Hers Health in Q1 2021 and held it in 17 quarters.
Royce & Associates's Hims & Hers Health position peaked at $11.1M in Q1 2021.
512 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2025.

Based on Royce & Associates's 13F filing for Q3 2025, filed 12 Nov 2025.